Literature DB >> 26603821

Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study.

Ningling Wang1, Yun Wang1, Qiuju Chen1, Jing Dong1, Hui Tian1, Yonglun Fu1, Ai Ai1, Qifeng Lyu1, Yanping Kuang1.   

Abstract

OBJECTIVE: We have previously reported a new luteal-phase ovarian stimulation (LPS) strategy for infertility treatment. The purpose of this study was to systematically assess the efficiency and safety of this strategy by comparing it with conventional ovarian stimulation protocols.
DESIGN: Retrospective cohort study.
SUBJECTS: Patients with normal ovarian reserve undergoing ovum pick-up (OPU) cycles between April 2012 and September 2013 were enrolled: 708 patients underwent the LPS protocol compared with 745 patients who underwent the mild treatment protocol and 1287 patients who underwent the short-term protocol. MEASUREMENTS: Number of mature oocytes retrieved and top-quality embryos obtained, implantation rate, pregnancy rate, live birth and ongoing pregnancy rate and neonatal outcomes.
RESULTS: The numbers of mature oocytes retrieved and top-quality embryos obtained per OPU cycle were significantly increased in the LPS group (10·9 ± 7·6 and 4·6 ± 4·3, respectively) compared with the mild treatment group (3·7 ± 3·0 and 1·8 ± 1·8, respectively, both P < 0·001) or the short-term group (9·1 ± 5·5 and 3·7 ± 3·1, respectively, both P < 0·001). Moreover, the total gonadotrophin used was also the highest in the LPS group. No significant differences were identified in the implantation rate (35·5% vs 34·8%, P > 0·05), pregnancy rate (46·2% vs 43·7%, P > 0·05) or live birth and ongoing pregnancy rate (44·4% vs 41·7%, P > 0·05) per frozen-thawed embryo transfer (FET) cycle in the LPS and mild treatment groups, respectively. However, the LPS protocol achieved a higher implantation rate (35·5% vs 31·8%, P = 0·012), pregnancy rate (46·2% vs 41·9%, P = 0·041), and live birth and ongoing pregnancy rate (44·4% vs 39·2%, P = 0·012) compared with the short-term protocol. Neonatal outcomes in the LPS group were similar to the other two groups.
CONCLUSIONS: The available data suggest that LPS is a feasible strategy for infertility treatment and complements the available follicular-phase ovarian stimulation strategies.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26603821     DOI: 10.1111/cen.12983

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  21 in total

1.  Similar miRNomic signatures characterize the follicular fluids collected after follicular and luteal phase stimulations in the same ovarian cycle.

Authors:  Danilo Cimadomo; Ramona Carmelo; Elvira Immacolata Parrotta; Stefania Scalise; Gianluca Santamaria; Erminia Alviggi; Maria Teresa De Angelis; Gianmarco Sarro; Alberto Vaiarelli; Roberta Venturella; Laura Rienzi; Fulvio Zullo; Filippo Maria Ubaldi; Giovanni Cuda
Journal:  J Assist Reprod Genet       Date:  2019-11-07       Impact factor: 3.412

2.  Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study.

Authors:  Yin-Mei Chen; Qian-Rong Qi; Qing-Zhen Xie; Yi-Fan Yang; Yi Xia; Xiao-Dan Zhou
Journal:  Curr Med Sci       Date:  2018-06-22

3.  What is the true place of a double stimulation and double oocyte retrieval in the same cycle for patients diagnosed with poor ovarian reserve? A systematic review including a meta-analytical approach.

Authors:  Konstantinos Sfakianoudis; Konstantinos Pantos; Sokratis Grigoriadis; Anna Rapani; Evangelos Maziotis; Petroula Tsioulou; Polina Giannelou; Adamantia Kontogeorgi; Agni Pantou; Nikolaos Vlahos; Michael Koutsilieris; Mara Simopoulou
Journal:  J Assist Reprod Genet       Date:  2019-12-03       Impact factor: 3.412

Review 4.  ART outcomes following ovarian stimulation in the luteal phase:a systematic review and meta-analysis.

Authors:  Buo-Jia Lu; Chien-Ju Lin; Bou-Zenn Lin; Li Huang; Li-Ting Chien; Chi-Huang Chen
Journal:  J Assist Reprod Genet       Date:  2021-05-25       Impact factor: 3.357

5.  Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.

Authors:  Qiuju Chen; Yun Wang; Lihua Sun; Shaozhen Zhang; Weiran Chai; Qingqing Hong; Hui Long; Li Wang; Qifeng Lyu; Yanping Kuang
Journal:  Reprod Biol Endocrinol       Date:  2017-09-05       Impact factor: 5.211

6.  Effect of Frozen Embryo Transfer and Progestin-primed Ovary Stimulation on IVF outcomes in women with high body mass index.

Authors:  Li Wang; Mingru Yin; Yali Liu; Qiuju Chen; Yun Wang; Ai Ai; Yonglun Fu; Zhiguang Yan; Wei Jin; Hui Long; Qifeng Lyu; Yanping Kuang
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

7.  Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats.

Authors:  Wen He; Xiaofeng Li; Daniel Adekunbi; Yali Liu; Hui Long; Li Wang; Qifeng Lyu; Yanping Kuang; Kevin T O'Byrne
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

8.  Can ovarian double-stimulation in the same menstrual cycle improve IVF outcomes?

Authors:  Maria Cecília de Almeida Cardoso; Alessandra Evangelista; Cássio Sartório; George Vaz; Caio Luis Vieira Werneck; Fernando Marques Guimarães; Paulo Gallo de Sá; Maria Cecília Erthal
Journal:  JBRA Assist Reprod       Date:  2017-09-01

9.  An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders.

Authors:  Chen-Yu Huang; Guan-Yeu Chen; Miawh-Lirng Shieh; Hsin-Yang Li
Journal:  Reprod Biol Endocrinol       Date:  2018-03-05       Impact factor: 5.211

10.  Lipidomic Components Alterations of Human Follicular Fluid Reveal the Relevance of Improving Clinical Outcomes in Women Using Progestin-Primed Ovarian Stimulation Compared to Short-Term Protocol.

Authors:  Xiaowei Wen; Yanping Kuang; Lixia Zhou; Baofeng Yu; Qiuju Chen; Yonglun Fu; Zheng Yan; Haiyan Guo; Qifeng Lyu; Jun Xie; Weiran Chai
Journal:  Med Sci Monit       Date:  2018-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.